We are live on !
Find out more
David Shaw D.E. Shaw & Co
AUM
$210B
Turnover
26.1%
1-Year Est. Return
57.28%
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
This Fund
S&P 500
This Quarter Est. Return
+28.4%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.63%
5 Year Est. Return
+213.1%
10 Year Est. Return
+910%
AUM
$210B
AUM Growth
+$43.9B
(+26%)
Cap. Flow
+$8.31B
Cap. Flow % of AUM
Cap. Flow %
3.95%
Top 10 Holdings %
Top 10 Hldgs %
15.14%
Holding
5,360
New
872
Increased
1,718
Reduced
1,611
Closed
527
Avg Time Held
Equity + Options
2.6
years
Top 10 Avg Time Held
Equity + Options
0.4
years
Top 20 Avg Time Held
Equity + Options
1.2
years
Avg Time Held Equity only
2.6
years
Top 10 Avg Time Held Equity only
1.4
years
Top 20 Avg Time Held Equity only
1.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$9.6B |
| 2 |
Amazon
AMZN
|
+$1.56B |
| 3 |
NVIDIA
NVDA
|
+$1.1B |
| 4 |
Meta Platforms (Facebook)
META
|
+$924M |
| 5 |
SpaceX
SPCX
|
+$907M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$2.17B |
| 2 |
Broadcom
AVGO
|
+$1.53B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
TSMC
TSM
|
+$928M |
| 5 |
Texas Instruments
TXN
|
+$904M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 33.7% |
| 2 | Technology | 18.77% |
| 3 | Financials | 8.35% |
| 4 | Healthcare | 7.91% |
| 5 | Consumer Discretionary | 7.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2826
CALL
Standex International
SXI
$2.76B
| $2.72M | ﹤0.01% |
7,600
+4,100
| +117% | +$1.15M |
2025 Q3
3 quarters
|
|
2827
CALL
Workday
WDAY
$46.5B
| $2.72M | ﹤0.01% |
22,200
-133,200
| -86% | -$16.9M |
2018 Q1
33 quarters
|
|
2828
CALL
Perpetua Resources
PPTA
$2.44B
| $2.72M | ﹤0.01% |
130,900
| – | – |
2026 Q1
1 quarter
|
|
2829
New Found Gold
NFGC
$661M
| $2.71M | ﹤0.01% |
1,758,915
-326,700
| -16% | -$626K |
2025 Q2
4 quarters
|
|
2830
State Street SPDR S&P Global Natural Resources ETF
GNR
$5.21B
| $2.71M | ﹤0.01% |
+40,272
| New | +$2.94M |
2026 Q2
0 quarters
|
|
2831
PUT
Vermilion Energy
VET
$1.58B
| $2.71M | ﹤0.01% |
290,000
+50,000
| +21% | +$594K |
2024 Q3
7 quarters
|
|
2832
Haemonetics
HAE
$5.46B
| $2.7M | ﹤0.01% |
36,040
-154,610
| -81% | -$9.9M |
2025 Q4
2 quarters
|
|
2833
TTM Technologies
TTMI
$7.01B
| $2.7M | ﹤0.01% |
14,446
+1,111
| +8% | +$179K |
2015 Q2
44 quarters
|
|
|
2834
Workday
WDAY
$46.5B
| $2.7M | ﹤0.01% |
22,069
-10,073
| -31% | -$1.28M |
2018 Q4
30 quarters
|
|
2835
Castle Biosciences
CSTL
$993M
| $2.69M | ﹤0.01% |
112,789
-99,177
| -47% | -$2.21M |
2024 Q4
6 quarters
|
|
2836
Rubrik
RBRK
$21.9B
| $2.69M | ﹤0.01% |
33,464
-277
| -0.8% | -$17.4K |
2024 Q4
6 quarters
|
|
2837
Zai Lab
ZLAB
$3.16B
| $2.68M | ﹤0.01% |
141,158
+77,915
| +123% | +$1.54M |
2024 Q1
9 quarters
|
|
2838
CALL
Fiverr
FVRR
$298M
| $2.67M | ﹤0.01% |
259,100
| – | – |
2026 Q1
1 quarter
|
|
2839
CALL
Ball Corp
BALL
$17.2B
| $2.67M | ﹤0.01% |
+42,800
| New | +$2.52M |
2026 Q2
0 quarters
|
|
2840
GeneDx Holdings
WGS
$1.86B
| $2.67M | ﹤0.01% |
38,877
+19,974
| +106% | +$1.14M |
2025 Q4
2 quarters
|
|
2841
People Inc
PPLI
$3.16B
| $2.67M | ﹤0.01% |
57,762
-3,366
| -6% | -$144K |
2025 Q3
3 quarters
|
|
2842
Old Second Bancorp
OSBC
$1.21B
| $2.67M | ﹤0.01% |
+114,326
| New | +$2.44M |
2026 Q2
0 quarters
|
|
2843
Universal Insurance Holdings
UVE
$1.29B
| $2.66M | ﹤0.01% |
64,380
+6,850
| +12% | +$258K |
2023 Q3
11 quarters
|
|
2844
CALL
BellRing Brands
BRBR
$1.07B
| $2.66M | ﹤0.01% |
205,300
-19,700
| -9% | -$238K |
2025 Q4
2 quarters
|
|
2845
Zumiez
ZUMZ
$215M
| $2.65M | ﹤0.01% |
149,052
+52,997
| +55% | +$1.18M |
2021 Q3
19 quarters
|
|
2846
Zentalis Pharmaceuticals
ZNTL
$163M
| $2.65M | ﹤0.01% |
546,566
-937,532
| -63% | -$3.74M |
2024 Q1
9 quarters
|
|
2847
CALL
Eldorado Gold
EGO
$9.29B
| $2.65M | ﹤0.01% |
85,200
| – | – |
2025 Q4
2 quarters
|
|
2848
Metallus
MTUS
$687M
| $2.64M | ﹤0.01% |
141,258
+72,260
| +105% | +$1.36M |
2014 Q3
47 quarters
|
|
2849
Arcturus Therapeutics
ARCT
$294M
| $2.64M | ﹤0.01% |
392,358
+140,324
| +56% | +$1.11M |
2025 Q2
4 quarters
|
|
2850
QDRO Acquisition Corp
QADR
| $2.64M | ﹤0.01% |
+266,001
| New | +$2.64M |
2026 Q2
0 quarters
|
|
Similar funds
David Shaw's Q2 2026 Portfolio in Review
As of Q2 2026, David Shaw held 5,360 positions worth $210B, up 26% from $166B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
David Shaw deployed $8.31B of net new capital in Q2 2026, opening 872 new positions and adding to 1,718 existing holdings. Its largest new stake was SpaceX: 5,340,000 shares worth $912M.
By sector, the portfolio is most concentrated in Miscellaneous at 34% of assets, up from 30% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Micron Technology, an estimated $2.17B trimmed.
- David Shaw's largest Q2 2026 buy was SpaceX: 5,340,000 shares worth $912M.
- David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $9.6B increase.
- David Shaw's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $2.17B.
- David Shaw fully exited Automatic Data Processing in Q2 2026, selling an estimated $241M.
- David Shaw's ten largest holdings make up 15% of its $210B portfolio in Q2 2026.
- David Shaw opened 872 new positions and closed 527 in Q2 2026.
- David Shaw's portfolio value rose 26% quarter-over-quarter to $210B.
Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.